J. Yang, M. Zhao, X. Zhou, M. Yan, X. Zhao, and F. Li, “Cost-Effectiveness of Sorafenib, Lenvatinib, and FOLFOX4 for Advanced Hepatocellular Carcinoma in China”, J Health Sci Med Res, vol. 43, no. 4, p. e20251153, Jun. 2025.